Case number 1:23-cv-01212
AbbVie Inc. v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 29, 2024 | 9 | SO ORDERED, granting 8 Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Jennifer L. Hall on 1/29/2024. (ceg) (Entered: 01/29/2024) (4) |
| Jan 29, 2024 | 10 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2; 11,690,845 B2; 11,690,854 B2; 11,707,464 B2. (Attachments: # 1 Order)(ceg) (Entered: 01/29/2024) (0) |
| Jan 26, 2024 | 8 | STIPULATION of Dismissal by AbbVie Inc.. (Tigan, Jeremy) (Entered: 01/26/2024) (4) |
| Jan 12, 2024 | N/A | SO ORDERED, re 7 Stipulation and Order to Extend Time for Sandoz to answer, move or otherwise respond to the Complaint to February 16, 2024. (*Reset Answer Deadlines: Sandoz Inc. answer due 2/16/2024). Ordered by Judge Jennifer L. Hall on 1/12/2024. (ceg) (Entered: 01/12/2024) (0) |
| Jan 11, 2024 | 7 | STIPULATION TO EXTEND TIME for Sandoz to answer, move or otherwise respond to the Complaint to February 16, 2024 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 01/11/2024) (2) |
| Jan 9, 2024 | N/A | Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (nms) (Entered: 01/09/2024) (0) |
| Dec 4, 2023 | 6 | STIPULATION and Proposed Order - filed by AbbVie Inc.. (Tigan, Jeremy) Modified on 12/4/2023 (nms). (Entered: 12/04/2023) (2) |
| Dec 4, 2023 | N/A | SO ORDERED, re 6 STIPULATION and Proposed Order (*Reset Answer Deadlines: Sandoz Inc. answer due 1/16/2024). Signed by Judge Richard G. Andrews on 12/4/2023. (nms) (Entered: 12/04/2023) (0) |
| Nov 1, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) (Entered: 11/01/2023) (0) |
| Oct 25, 2023 | 1 | Complaint* (1) |
| Oct 25, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 10/25/2023) (3) |
| Oct 25, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 16, 2023. Date of Expiration of Patent: See Attached. (jfm) (Entered: 10/25/2023) (2) |
| Oct 25, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2; 11,690,845 B2; 11,690,854 B2; 11,707,464 B2. (jfm) (Entered: 10/25/2023) (1) |
| Oct 25, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (jfm) (Entered: 10/25/2023) (1) |
| Oct 25, 2023 | N/A | No Summons Issued. (jfm) (Entered: 10/25/2023) (0) |
